Business Wire

TX-TANGO-NETWORKS

12.3.2024 14:01:28 CET | Business Wire | Press release

Share
Tango Networks, the Leader in Business Mobile Telecommunications, Is Excited to Announce the Launch of Its Latest Innovation, Global Pass

Tango Networks today announced Global Pass, a single rate subscription plan for Tango Extend across 39 countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312069630/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tango Extend Global Pass sets the new benchmark for global business mobile communications under a single subscription plan. (Photo: Business Wire)

The Tango Extend eSIM service already enables any subscriber’s smartphone to integrate directly with a company’s Unified Communications (UC) platform to provide remote employees, frontline, deskless and hybrid workers with seamless business communications.

Now, with Global Pass, Tango Extend subscribers enjoy a single fixed-rate business mobile service across 14 Home countries with seamless roaming in a further 25 Home Away countries across Europe and North America.

Global Pass is a game-changer, enhancing the capabilities of Tango Extend to redefine how enterprises connect, communicate, and collaborate on a global basis,” said Lee Essex, Senior Vice President of Sales for Tango Networks. "With Global Pass, we empower enterprises to break free from traditional connectivity and geography constraints, fostering a new era of productivity and collaboration for the extended workforce."

Global Coverage with Borderless Roaming in 39 Countries

Global Pass liberates mobile communication from borders, enabling employees to stay connected effortlessly while traveling or working internationally.

Starting with 14 countries in the first half of 2024, Global Pass subscribers based in the USA, UK, Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Mexico, Luxembourg, Spain, Sweden, and Poland will be able to be resident or move freely between these countries and roam into 25 more countries across Europe and North America without the fear of incurring additional 'roaming' charges. Check coverage availability here: https://tango-networks.com/country-availability/

Later in 2024 and into 2025, Global Pass will expand to countries across Asia, Australasia, North and South America.

Seamless Integration for Mobile UC

Integrating with many leading UC platforms including Microsoft’s Teams Phone, Tango Extend enables workers to use their existing business numbers natively on their mobile phones, including Bring-Your-Own-Device (BYOD) mobile phones. Tango Extend provides a business e-SIM for any multi-SIM personal mobile phone. The eSIM is paid for and controlled by the business, allowing work communications and personal communications to be securely separated with dual personas. Business calls are made using the phone’s native dialer, rather than a mobile app.

Companies using Tango Extend are retiring landline desk phones, cutting expensive company-issued mobile phones, whilst at the same time reducing their carbon footprint and boosting worker productivity.

Incorporating groundbreaking fixed-mobile convergence technologies, Tango Extend is covered by more than 100 patents and has won more than 10 best new product and channel solution awards.

About Tango Networks:

Tango Networks is a pioneering force in providing cutting-edge mobile telecommunications solutions for enterprises globally. With a focus on innovation and customer-centricity, Tango Networks continues to revolutionize how businesses connect and communicate in a mobile-centric world.

Global Pass is available for immediate deployment, offering enterprises a transformative approach to mobile connectivity. For more details on Global Pass and Tango Networks' comprehensive suite of mobile telecommunications solutions, please visit tango-networks.com.

Tango Extend is a trademark of Tango Networks Inc.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312069630/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release

Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co

Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release

Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release

Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and

LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release

The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release

Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye